Masimo Valuation Multiples

Discover Masimo's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Glaukos, Demant, Bruker, Globus Medical and more.

Masimo Overview

About Masimo

Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.


Founded

1989

HQ

United States

Employees

9.2K

Website

masimo.com

Financials (FY)

Revenue: -
Net Income: -

EV

$9.8B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Masimo Stock Performance

Masimo has current market cap of $9.4B, and enterprise value of $9.8B.

Market Cap Evolution


Masimo's stock price is $179.95.

Masimo share price increased by 17.0% in the last year.

See more trading valuation data for Masimo
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$9.8B$9.4B0.0%-0.9%17.0%-

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Masimo Valuation Multiples

Masimo Financial Valuation Multiples

As of July 19, 2026, Masimo has market cap of $9.4B and EV of $9.8B.

LTMLast FY202320242025202620272028

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Masimo Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

Masimo Competitors

Masimo competitors include Glaukos, Demant, Bruker, Globus Medical, Bio-Rad Laboratories, Insulet, Shimadzu, Olympus, Baxter International and Zydus Lifesciences.

Most Masimo public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Glaukos17.8x15.7x(274.3x)716.9x
Demant3.3x3.1x13.9x13.3x
Bruker3.0x3.0x19.4x17.5x
Globus Medical3.4x3.2x10.8x9.9x
Bio-Rad Laboratories3.1x3.1x6.6x18.5x
Insulet4.4x3.9x18.5x16.2x
Shimadzu1.8x1.8x10.3x10.7x
Olympus1.8x1.8x10.9x10.2x

This data is available for Pro users. Sign up to see all Masimo competitors and their valuation data.

Start Free Trial

Acquisitions by Masimo

Masimo has acquired 4 companies to date.

Last acquisition by Masimo was on April 20th 2023. Masimo acquired nura for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Masimo

nura
Sound United
Lidco
TNI medical
Description
nura is an Australian audio company known for the Nuraphone headphones, which feature biometric sensors to measure hearing profiles from outer ear to brain and customize sound output. Founded in 2014 in Melbourne, the technology adapts EQ settings automatically upon wear detection. The Nuraphone supports wireless Bluetooth connectivity and immersive 360-degree audio. nura has expanded to true wireless earbuds and sells through retailers in Europe, Asia, and North America, with patents on its sensory technology.
Sound United is a consumer audio company owning brands Polk Audio, Definitive Technology, and Denon home theater systems. Montebello, California-headquartered after a 2017 merger with D+M Holdings, it manufactures wireless speakers, soundbars, and AV receivers distributed globally via Best Buy and Amazon. The portfolio includes Marantz hi-fi amplifiers and HEOS multi-room streaming compatible with AirPlay 2.
LiDCO is a Cambridge-headquartered medical device company manufacturing non-invasive and minimally invasive hemodynamic monitoring systems. Its LiDCOplus and LiDCOrapid monitors measure pulse contour analysis for cardiac output, oxygen delivery, and fluid responsiveness in ICU and surgical settings. Deployed in over 2,000 hospitals globally, the technology supports goal-directed therapy reducing complications in high-risk patients. Since introducing its first product in 1999, LiDCO integrates with existing clinical monitors for real-time hemodynamic optimization.
TNI medical is a medical device company headquartered in Freiburg, Germany, specializing in non-invasive respiratory therapy equipment. The firm develops the SoftFlow system, a high-flow nasal cannula device that delivers heated, humidified oxygen to improve patient comfort during ventilation. Production facilities operate in Würzburg and Dessau in Germany, alongside a U.S. site in Baltimore, Maryland. Founded in 2007, TNI medical distributes its products to hospitals and clinics worldwide, emphasizing therapy for chronic obstructive pulmonary disease and acute respiratory distress.
HQ CountryAustraliaUnited StatesUnited KingdomGermany
HQ City
Melbourne
San Diego, CA
London
Freiburg
Deal Date20 Apr 202315 Feb 20222 Nov 202020 Mar 2020
Valuationundisclosed$1B$40M$33M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Masimo acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Masimo

Masimo has invested in 1 company to date.

Latest investment by Masimo was on January 3rd 2018. Masimo invested in StartUp Health in their $19M Undisclosed stage round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Masimo

StartUp Health
Description
StartUp Health is a New York-headquartered venture platform founded in 2011 that invests in over 400 health technology companies spanning six continents and 26 countries. Its portfolio targets moonshots in access to care, disease cures, women's health, mental health, longevity, and pandemic response, with companies collectively raising more than $2 billion. Backed by investors such as Kaiser Permanente, Novartis, Steve Case, and Mark Cuban, the platform delivers decade-long support including capital, expert networks, and strategic collaborations.
HQ CountryUnited States
HQ City
New York City, NY
Deal Date3 Jan 2018
RoundUndisclosed stage
Raised$19M
InvestorsPing An; GuideWell; Masimo
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Masimo investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Masimo

When was Masimo founded?Masimo was founded in 1989.
Where is Masimo headquartered?Masimo is headquartered in United States.
How many employees does Masimo have?As of today, Masimo has over 9K employees.
Who is the CEO of Masimo?Masimo's CEO is Catherine M. Szyman.
Is Masimo publicly listed?Yes, Masimo is a public company listed on Düsseldorf Stock Exchange.
What is the stock symbol of Masimo?Masimo trades under 3M4 ticker.
When did Masimo go public?Masimo went public in 2007.
Who are competitors of Masimo?Masimo main competitors include Glaukos, Demant, Bruker, Globus Medical, Bio-Rad Laboratories, Insulet, Shimadzu, Olympus, Baxter International, Zydus Lifesciences.
What is the current market cap of Masimo?Masimo's current market cap is $9.4B.
Is Masimo profitable?No, Masimo is not profitable.
How many companies Masimo has acquired to date?As of July 2026, Masimo has acquired 4 companies.
What was the largest acquisition by Masimo?$1B acquisition of Sound United on 15th February 2022 was the largest M&A Masimo has done to date.
What companies Masimo acquired?Masimo acquired Sound United, Lidco, TNI medical, and nura.
In how many companies Masimo has invested to date?As of July 2026, Masimo has invested in 1 company.
What was the last Masimo investment?On 3rd January 2018 Masimo invested in StartUp Health, participating in a $19M Undisclosed stage round, alongside Ping An and GuideWell.
In what companies Masimo invested in?Masimo invested in StartUp Health.

See public comps similar to Masimo

Lists including Masimo

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial